Combination therapy for HIV: Towards long term control of disease progression

Expert Opinion on Investigational Drugs

Volumn 7, Issue 6, 1998, Pages 941-961

  Conway, B ^a   Routy, J P ^a   Sekaly, R P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antiretroviral; Combination therapy; Human immunodeficiency virus; Hydroxyurea; Induction maintenance therapy; Non nucleoside reverse transcriptase inhibitor; Nucleoside analogue; Protease inhibitor

Indexed keywords

ABACAVIR; ADEFOVIR; ADEFOVIR DIPIVOXIL; AMPRENAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; HYDROXYUREA; INDINAVIR; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; DISEASE COURSE; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OPPORTUNISTIC INFECTION; REVIEW;

EID: 0031838611     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.7.6.941     Document Type: Review

References (113)